+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephalosporin"

Oral Antibiotics Market 2025-2033 - Product Thumbnail Image

Oral Antibiotics Market 2025-2033

  • Report
  • March 2025
  • 147 Pages
  • Global
From
Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029 - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 200 Pages
  • Global
From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
Antibiotics Market Report 2023-2033 - Product Thumbnail Image

Antibiotics Market Report 2023-2033

  • Report
  • January 2023
  • 388 Pages
  • Global
From
UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 79 Pages
  • United Arab Emirates United Arab Emirates
From
Beta-Lactamase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Cephalosporin market is a segment of the Antibiotics market. Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from a fungus called Cephalosporium and are divided into four generations based on their antibacterial activity. Cephalosporins are used to treat infections caused by Gram-positive and Gram-negative bacteria, including respiratory, urinary tract, skin, and soft tissue infections. Cephalosporins are widely used in both human and veterinary medicine. They are available in various formulations, including tablets, capsules, suspensions, and injections. The global Cephalosporin market is driven by the increasing prevalence of bacterial infections, the growing demand for generic drugs, and the increasing use of Cephalosporins in veterinary medicine. Some of the major companies in the Cephalosporin market include Pfizer, Merck, Sanofi, Novartis, GlaxoSmithKline, AstraZeneca, and Allergan. Show Less Read more